TASHKENT, Feb 12 (NNN-CAN) – Uzbekistan launched a process to register Russia’s Sputnik V vaccine against COVID-19, Uzbek Health Ministry press service said, yesterday.
According to the ministry, Uzbekistan’s special commission against the pandemic, reviewed results of the third stage clinical trials of Sputnik V. “And it was approved that it is possible to start the certification and registration process at the initial stage,” the report said.
Uzbekistan also conducted the third-stage clinical trials of COVID-19 vaccine developed by China’s Anhui Zhifei Longcom Biopharmaceutical, on more than 7,000 volunteers since Dec last year, and so far, no side effects have been observed, the report said.
Earlier this month, Uzbek health authorities said, they will increase the number of volunteers up to 9,000, instead of 5,000 as planned initially.
So far, Uzbekistan registered 79,303 confirmed COVID-19 cases and 622 related deaths.– NNN-CAN